Exercise and Neuroinflammation in Health and Disease

키워드

참고문헌 (102)

1. Shabab T, "Neuroinflammation pathways : a general review", Int J Neurosci, 127, pp.624~633 (2017)
2. Carson MJ, "The cellular response in neuroinflammation : the role of leukocytes, microglia and astrocytes in neuronal death and survival", Clin Neurosci Res, 6, pp.237~245 (2006)
3. Fernandes-Alnemri T, "AIM2activates the inflammasome and cell death in response to cytoplasmic DNA", Nature, 458, pp.509~513 (2009)
4. Lyman M, "Neuroinflammation : the role and consequences", Neurosci Res, 79, pp.1~12 (2014)
5. Ebert SE, "Molecular imaging of neuroinflammation in patients after mild traumatic brain injury : a longitudinal(123)I-CLINDE single photon emission computed tomography study", Eur J Neurol, 26, pp.1426~1432 (2019)
6. Gendelman HE, "Neural immunity : Friend or foe?", J Neurovirol, 8, pp.474~479 (2002)
7. Schain M, "Neuroinflammation in neurodegenerative disorders-a review", Curr Neurol Neurosci Rep, 17, pp.25~ (2017)
8. Das Sarma J, "Microglia-mediated neuroinflammation is an amplifier of virus-induced neuropathology", J Neurovirol, 20, pp.122~136 (2014)
9. de Vries HE, "The influence of cytokines on the integrity of the blood-brain barrier in vitro", J Neuroimmunol, 64, pp.37~43 (1996)
10. Laflamme N, "An essential role of interleukin-1β in mediating NF-kappaB activity and COX-2 transcription in cells of the blood-brain barrier in response to a systemic and localized inflammation but not during endotoxemia", J Neurosci, 19, pp.10923~10930 (1999)
11. Kitazawa M, "Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer’s disease", J Neurosci, 25, pp.8843~8853 (2005)
12. Cunningham AJ, "Interleukin-1β(IL-1 beta)and tumour necrosis factor(TNF)inhibit long-term potentiation in the rat dentate gyrus in vitro", Neurosci Lett, 203, pp.17~20 (1996)
13. Ortiz GG, "Role of the blood-brain barrier in multiple sclerosis", Arch Med Res, 45, pp.687~697 (2014)
14. Sweeney MD, "Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders", Nat Rev Neurol, 14, pp.133~150 (2018)
15. Desai BS, "Blood-brain barrier pathology in Alzheimer’s and Parkinson’s disease : implications for drug therapy", Cell Transplant, 16, pp.285~299 (2007)
16. Garbuzova-Davis S, "Blood-CNS Barrier Impairment in ALS patients versus an animal model", Front Cell Neurosci, 8, pp.21~ (2014)
17. Harry GJ, "Microglia in the developing brain : a potential target with lifetime effects", Neurotoxicology, 33, pp.191~206 (2012)
18. Glass CK, "Mechanisms underlying inflammation in neurodegeneration", Cell, 140, pp.918~934 (2010)
19. Akbar M, "Mitochondrial dysfunction and cell death in neurodegenerative diseases through nitroxidative stress", Brain Res, 1637, pp.34~55 (2016)
20. Cotman CW, "Exercise builds brain health : key roles of growth factor cascades and inflammation", Trends Neurosci, 30, pp.464~472 (2007)
21. Rothman SM, "Brain-derived neurotrophic factor as a regulator of systemic and brain energy metabolism and cardiovascular health", Ann N Y Acad Sci, 1264, pp.49~63 (2012)
22. Voss MW, "Bridging animal and human models of exercise-induced brain plasticity", Trends Cogn Sci, 17, pp.525~544 (2013)
23. 유수지, "Effects of Acute Exercise on Mitochondrial Function, Dynamics, and Mitophagy in Rat Cardiac and Skeletal Muscles", International Neurourology Journal, 23, pp.22~31 (2019), 대한배뇨장애요실금학회[DOI]
24. Mee-Inta O, "Physical exercise inhibits inflammation and microglial activation", 8(7), pp.E691~ (2019)[DOI]
25. 유수지, "Effects of a single bout of exercise on mitochondria-mediated apoptotic signaling in rat cardiac and skeletal muscles", Journal of exercise rehabilitation, 15(4), pp.512~517 (2019), 한국운동재활학회[DOI]
26. 유수지, "Role of exercise in age-related sarcopenia", Journal of exercise rehabilitation, 14(4), pp.551~558 (2018), 한국운동재활학회
27. Nagamatsu LS, "Exercise is medicine, for the body and the brain", Br J Sports Med, 48, pp.943~944 (2014)
28. Gomez-Cabrera MC, "Moderate exercise is an antioxidant : upregulation of antioxidant genes by training", Free Radic Biol Med, 44, pp.126~131 (2008)
29. Ferreira GD, "Respiratory training improved ventilatory function and respiratory muscle strength in patients with multiple sclerosis and lateral amyotrophic sclerosis : systematic review and meta-analysis", Physiotherapy, 102, pp.221~228 (2016)
30. Braga ACM, "The role of moderate aerobic exercise as determined by cardiopulmonary exercise testing in ALS", Neurol Res Int, 2018, pp.8218697~ (2018)
31. 박상서, "Treadmill Exercise Ameliorates Chemotherapy-Induced Muscle Weakness and Central Fatigue by Enhancing Mitochondrial Function and Inhibiting Apoptosis", International Neurourology Journal, 23, pp.32~39 (2019), 대한배뇨장애요실금학회[DOI]
32. Filiano AJ, "Interactions of innate and adaptive immunity in brain development and function", Brain Res, 1617, pp.18~27 (2015)
33. Gehrmann J, "Microglia : intrinsic immuneffector cell of the brain", Brain Res Brain Res Rev, 20, pp.269~287 (1995)
34. Park SE, "Kaempferol acts through mitogen-activated protein kinases and protein kinase B", AKT to elicit protection in a model of neuroinflammation in BV2microglial cells, 2011, pp.164, 1008~1025
35. Gilmore TD, "Introduction to NF-kappaB : players, pathways, perspectives", Oncogene, 25, pp.6680~6684 (2006)
36. Huang WC, "Beyond NF-kappaB activation : nuclear functions of IkappaB kinase alpha", J Biomed Sci, 20, pp.3~ (2013)
37. Okun E, "Toll-like receptors in neurodegeneration", Brain Res Rev, 59, pp.278~292 (2009)
38. Wang L, "Arsenic modulates heme oxygenase-1, interleukin-6, and vascular endothelial growth factor expression in endothelial cells : roles of ROS, NF-kappaB, and MAPK pathways", Arch Toxicol, 86, pp.879~896 (2012)
39. Allan SM, "Inflammation in central nervous system injury", Philos Trans R Soc Lond B Biol Sci, 358, pp.1669~1677 (2003)
40. Cumiskey D, "A role for inflammatory mediators in the IL-18 mediated attenuation of LTP in the rat dentate gyrus", Neuropharmacology, 52, pp.1616~1623 (2007)
41. Nitsch R, "Human brain-cell death induced by tumournecrosis-factor-related apoptosis-inducing ligand(TRAIL)", Lancet, 356, pp.827~828 (2000)
42. Blamire AM, "Interleukin-1β-induced changes in blood-brain barrier permeability, apparent diffusion coefficient, and cerebral blood volume in the rat brain : a magnetic resonance study", J Neurosci, 20, pp.8153~8159 (2000)
43. Swaroop S, "HSP60 plays a regulatory role in IL-1β-induced microglial inflammation via TLR4-p38 MAPK axis", J Neuroinflammation, 13, pp.27~ (2016)
44. Galluzzi L, "Mitochondria : master regulators of danger signalling", Nat Rev Mol Cell Biol, 13, pp.780~788 (2012)
45. Mathew A, "Degraded mitochondrial DNA is a newly identified subtype of the damage associated molecular pattern(DAMP)family and possible trigger of neurodegeneration", J Alzheimers Dis, 30, pp.617~627 (2012)
46. Andreeva TV, "Biological basis for amyloidogenesis in Alzheimer’s disease", Biochemistry(Mosc), 82, pp.122~139 (2017)
47. Trovato Salinaro A, "Neuroinflammation and neurohormesis in the pathogenesis of Alzheimer’s disease and Alzheimer-linked pathologies : modulation by nutritional mushrooms", Immun Ageing, 15, pp.8~ (2018)
48. Calsolaro V, "Neuroinflammation in Alzheimer’s disease : current evidence and future directions", Alzheimers Dement, 12, pp.719~732 (2016)
49. Morales I, "Neuroinflammation in the pathogenesis of Alzheimer’s disease. A rational framework for the search of novel therapeutic approaches", Front Cell Neurosci, 8, pp.112~ (2014)
50. McNaull BB, "Inflammation and anti-inflammatory strategies for Alzheimer’s disease--a minireview", Gerontology, 56, pp.3~14 (2010)
51. Heneka MT, "Innate immune activation in neurodegenerative disease", Nat Rev Immunol, 14, pp.463~477 (2014)
52. Tansey MG, "Neuroinflammatory mechanisms in Parkinson’s disease : potential environmental triggers, pathways, and targets for early therapeutic intervention", Exp Neurol, 208, pp.1~25 (2007)
53. Kalia LV, "Parkinson’s disease", Lancet, 386, pp.896~912 (2015)
54. Mahlknecht P, "Is there a need to redefine Parkinson’s disease?", J Neural Transm (Vienna), 120(Suppl 1), pp.S9~17 (2013)
55. Marques O, "Alpha-synuclein : from secretion to dysfunction and death", Cell Death Dis, 3, pp.e350~ (2012)
56. Morris JK, "Insulin resistance impairs nigrostriatal dopamine function", Exp Neurol, 231, pp.171~180 (2011)
57. Zhang W, "Aggregated α-synuclein activates microglia : a process leading to disease progression in Parkinson’s disease", FASEB J, 19, pp.533~542 (2005)
58. Banati RB, "Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson’s disease", Mov Disord, 13, pp.221~227 (1998)
59. Nagatsu T, "Cytokines in Parkinson’s disease", J Neural Transm Suppl, (58), pp.143~151 (2000)
60. Reynolds AD, "Nitrated alpha-synuclein-activated microglial profiling for Parkinson’s disease", J Neurochem, 104, pp.1504~1525 (2008)
61. Ruberg M, "Neuronal death caused by apoptosis in Parkinson disease", Rev Neurol(Paris), 153, pp.499~508 (1997)
62. Just-Borràs L, "Running and swimming prevent the deregulation of the BDNF", TrkB neurotrophic signalling at the neuromuscular junction in mice with amyotrophic lateral sclerosis, 2019, ~
63. Brites D, "Microglia centered pathogenesis in ALS : insights in cell interconnectivity", Front Cell Neurosci, 8, pp.117~ (2014)
64. Meissner F, "Mutant superoxide dismutase 1-induced IL-1β accelerates ALS pathogenesis", Proc Natl Acad Sci U S A, 107, pp.13046~13050 (2010)
65. Watanabe M, "Histological evidence of protein aggregation in mutant SOD1 transgenic mice and in amyotrophic lateral sclerosis neural tissues", Neurobiol Dis, 8, pp.933~941 (2001)
66. Forsberg K, "Misfolded SOD1 inclusions in patients with mutations in C9orf72 and other ALS", FTD-associated genes, 2019, pp.90, 861~869
67. Gordon R, "Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in mice", Sci Transl Med, 10(465), pp.eaah4066~ (2018)[DOI]
68. Moreno B, "Systemic inflammation induces axon injury during brain inflammation", Ann Neurol, 70, pp.932~942 (2011)
69. Fransson ME, "The T-cell pool is anergized in patients with multiple sclerosis in remission", Immunology, 126, pp.92~101 (2009)
70. Hauser SL, "B-cell depletion with rituximab in relapsing-remitting multiple sclerosis", N Engl J Med, 358, pp.676~688 (2008)
71. Tzartos JS, "Interleukin-17 production in central nervous systeminfiltrating T cells and glial cells is associated with active disease in multiple sclerosis", Am J Pathol, 172, pp.146~155 (2008)
72. Kim D, "Protective effect of exercise training against the progression of Alzheimer’s disease in 3xTg-AD mice", Behav Brain Res, 374, pp.112105~ (2019)
73. Kim D, "Exercise attenuates high-fat diet-induced disease progression in 3xTg-AD mice", Med Sci Sports Exerc, 49, pp.676~686 (2017)
74. Kohman RA, "Wheel running attenuates microglia proliferation and increases expression of a proneurogenic phenotype in the hippocampus of aged mice", Brain Behav Immun, 26, pp.803~810 (2012)
75. Barrientos RM, "Little exercise, big effects : reversing aging and infection-induced memory deficits, and underlying processes", J Neurosci, 31, pp.11578~11586 (2011)
76. Tapia-Rojas C, "Voluntary running attenuates memory loss, decreases neuropathological changes and induces neurogenesis in a mouse model of Alzheimer’s disease", Brain Pathol, 26, pp.62~74 (2016)
77. Rodriguez JJ, "Microglial response to Alzheimer’s disease is differentially modulated by voluntary wheel running and enriched environments", Brain Struct Funct, 220, pp.941~953 (2015)
78. Zhang X, "Treadmill exercise decreases abeta deposition and counteracts cognitive decline in APP", PS1 mice, possibly via hippocampal microglia modifications, 2019, pp.11, 78~
79. Um HS, "Exercise training acts as a therapeutic strategy for reduction of the pathogenic phenotypes for Alzheimer’s disease in an NSE", APPsw-transgenic model, 2008, pp.22, 529~539
80. Bo H, "Exercise-induced neuroprotection of hippocampus in APP", PS1 transgenic mice via upregulation of mitochondrial 8-oxoguanine DNA glycosylase, 2014, pp.2014, 834502~
81. 김보균, "Impact of Several Types of Stresses on Short-term Memory and Apoptosis in the Hippocampus of Rats", International Neurourology Journal, 17(3), pp.114~120 (2013), 대한배뇨장애요실금학회[DOI]
82. 허유미, "Treadmill Exercise Ameliorates Short-Term Memory Disturbance in Scopolamine-Induced Amnesia Rats", International Neurourology Journal, 18(1), pp.16~22 (2014), 대한배뇨장애요실금학회
83. Ba F, "Parkinson disease : the relationship between non-motor symptoms and motor phenotype", Can J Neurol Sci, 43, pp.261~267 (2016)
84. Dauer W, "Parkinson’s disease : mechanisms and models", Neuron, 39, pp.889~909 (2003)
85. van der Kolk NM, "Effectiveness of home-based and remotely supervised aerobic exercise in Parkinson’s disease : a double-blind, randomised controlled trial", Lancet Neurol, 18, pp.998~1008 (2019)
86. Tang L, "The effects of exercise interventions on Parkinson’s disease : a Bayesian network meta-analysis", J Clin Neurosci, 70, pp.47~54 (2019)
87. Real CC, "Treadmill exercise prevents increase of neuroinflammation markers involved in the dopaminergic damage of the 6-OHDA Parkinson’s disease model", J Mol Neurosci, 63, pp.36~49 (2017)
88. Tuon T, "Physical training exerts neuroprotective effects in the regulation of neurochemical factors in an animal model of Parkinson’s disease", Neuroscience, 227, pp.305~312 (2012)
89. Koo JH, "Treadmill exercise produces neuroprotective effects in a murine model of Parkinson’s disease by regulating the TLR2", MyD88, Neuroscience, pp.2017, 356[DOI]
90. Frazzitta G, "Intensive rehabilitation treatment in early Parkinson’s disease : a randomized pilot study with a 2-year follow-up", Neurorehabil Neural Repair, 29, pp.123~131 (2015)
91. Zoladz JA, "Moderate-intensity interval training increases serum brain-derived neurotrophic factor level and decreases inflammation in Parkinson’s disease patients", J Physiol Pharmacol, 65, pp.441~448 (2014)
92. Bloomer RJ, "Effect of resistance training on blood oxidative stress in Parkinson disease", Med Sci Sports Exerc, 40, pp.1385~1389 (2008)
93. 이재민, "Treadmill Exercise Improves Motor Function by Suppressing Purkinje Cell Loss in Parkinson Disease Rats", International Neurourology Journal, 22, pp.147~155 (2018), 대한배뇨장애요실금학회
94. Flis DJ, "Swim training modulates skeletal muscle energy metabolism, oxidative stress, and mitochondrial cholesterol content in amyotrophic lateral sclerosis mice", Oxid Med Cell Longev, 2018, pp.5940748~ (2018)
95. Flis DJ, "Swim training modulates mouse skeletal muscle energy metabolism and ameliorates reduction in grip strength in a mouse model of amyotrophic lateral sclerosis", Int J Mol Sci, 20(2), pp.E233~ (2019)[DOI]
96. Kassa RM, "Effect of physical exercise and anabolic steroid treatment on spinal motoneurons and surrounding glia of wild-type and ALS mice", Brain Res, 1657, pp.269~278 (2017)
97. Lisle S, "Amyotrophic lateral sclerosis : the role of exercise", Curr Sports Med Rep, 14, pp.45~46 (2015)
98. Kierkegaard M, "High-intensity resistance training in multiple sclerosis-An exploratory study of effects on immune markers in blood and cerebrospinal fluid, and on mood, fatigue, health-related quality of life, muscle strength, walking and cognition", J Neurol Sci, 362, pp.251~257 (2016)
99. White LJ, "Cytokine responses to resistance training in people with multiple sclerosis", J Sports Sci, 24, pp.911~914 (2006)
100. Donia SA, "The effects of acute aerobic exercise on mood and inflammation in individuals with multiple sclerosis and incomplete spinal cord injury", Neuro-Rehabilitation, 45, pp.117~124 (2019)
101. Ozkul C, "Effect of combined exercise training on serum brain-derived neurotrophic factor, suppressors of cytokine signaling 1 and 3 in patients with multiple sclerosis", J Neuroimmunol, 316, pp.121~129 (2018)
102. Castellano V, "Cytokine responses to acute and chronic exercise in multiple sclerosis", J Appl Physiol(1985), 104, pp.1697~1702 (2008)

관련 논문AI추천